UnitedHealth Group Incorporated $UNH Shares Bought by Cassia Capital Partners LLC

Cassia Capital Partners LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,094 shares of the healthcare conglomerate’s stock after buying an additional 93 shares during the period. Cassia Capital Partners LLC’s holdings in UnitedHealth Group were worth $653,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of UNH. Missouri Trust & Investment Co grew its stake in UnitedHealth Group by 15.9% in the second quarter. Missouri Trust & Investment Co now owns 4,873 shares of the healthcare conglomerate’s stock worth $1,520,000 after purchasing an additional 669 shares in the last quarter. Regatta Capital Group LLC lifted its stake in UnitedHealth Group by 38.3% during the second quarter. Regatta Capital Group LLC now owns 978 shares of the healthcare conglomerate’s stock worth $305,000 after purchasing an additional 271 shares during the last quarter. Wealth Effects LLC raised its holdings in shares of UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after purchasing an additional 591 shares during the period. Shulman DeMeo Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 11.7% in the 2nd quarter. Shulman DeMeo Asset Management LLC now owns 915 shares of the healthcare conglomerate’s stock valued at $285,000 after buying an additional 96 shares during the period. Finally, Evanson Asset Management LLC lifted its holdings in UnitedHealth Group by 33.6% in the second quarter. Evanson Asset Management LLC now owns 1,065 shares of the healthcare conglomerate’s stock worth $332,000 after acquiring an additional 268 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.2%

Shares of NYSE UNH opened at $351.87 on Thursday. The business has a fifty day simple moving average of $298.81 and a 200-day simple moving average of $362.32. The company has a market cap of $318.68 billion, a price-to-earnings ratio of 15.25, a P/E/G ratio of 2.27 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Barclays increased their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. KeyCorp decreased their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Oppenheimer reduced their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Finally, Morgan Stanley lifted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.